Carregant...

Elevations in Circulating sST2 Levels are Associated with In-hospital Mortality and Adverse Clinical Outcomes following Blunt Trauma

BACKGROUND: Soluble suppression of tumorigenicity 2 (sST2), a decoy receptor for interleukin (IL)-33, has emerged as a novel biomarker in various disease processes. Recent studies have elucidated the role of the sST2/IL-33 complex in modulating the balance of Th1/Th2 immune responses following tissu...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Surg Res
Autors principals: Billiar, Isabel, Guardado, Jesse, Abdul-Malak, Othman, Vodovotz, Yoram, Billiar, Timothy R., Namas, Rami A.
Format: Artigo
Idioma:Inglês
Publicat: 2019
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6815699/
https://ncbi.nlm.nih.gov/pubmed/31279260
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jss.2019.05.057
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!